252 related articles for article (PubMed ID: 31710437)
1. Function of Long Noncoding RNA UCA1 on Gastric Cancer Cells and its Clinicopathological Significance in Plasma.
Tang X; Yu L; Bao J; Jiang P; Yan F
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710437
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
3. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
4. TGFβ1-Induced LncRNA UCA1 Upregulation Promotes Gastric Cancer Invasion and Migration.
Zuo ZK; Gong Y; Chen XH; Ye F; Yin ZM; Gong QN; Huang JS
DNA Cell Biol; 2017 Feb; 36(2):159-167. PubMed ID: 28075173
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
6. UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p.
Gu L; Lu LS; Zhou DL; Liu ZC
Cancer Med; 2018 Apr; 7(4):1253-1263. PubMed ID: 29516678
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma.
Qin L; Jia Z; Xie D; Liu Z
J Cell Biochem; 2018 Dec; 119(12):10075-10086. PubMed ID: 30129054
[TBL] [Abstract][Full Text] [Related]
8. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer.
Gong P; Qiao F; Wu H; Cui H; Li Y; Zheng Y; Zhou M; Fan H
Cell Death Dis; 2018 Nov; 9(12):1158. PubMed ID: 30464170
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of UCA1 in gastric cancer and its clinical significance.
Zheng Q; Wu F; Dai WY; Zheng DC; Zheng C; Ye H; Zhou B; Chen JJ; Chen P
Clin Transl Oncol; 2015 Aug; 17(8):640-6. PubMed ID: 25903045
[TBL] [Abstract][Full Text] [Related]
10. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
11. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.
Yang A; Liu X; Liu P; Feng Y; Liu H; Gao S; Huo L; Han X; Wang J; Kong W
Cell Mol Biol Lett; 2021 Jul; 26(1):33. PubMed ID: 34238213
[TBL] [Abstract][Full Text] [Related]
12. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
14. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
[TBL] [Abstract][Full Text] [Related]
15. Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer.
Li C; Liang G; Yao W; Sui J; Shen X; Zhang Y; Ma S; Ye Y; Zhang Z; Zhang W; Yin L; Pu Y
Oncol Rep; 2016 Mar; 35(3):1529-40. PubMed ID: 26718650
[TBL] [Abstract][Full Text] [Related]
16. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
17. Determination of serum RP11-731F5.2 as a noninvasive biomarker for gastric cancer diagnosis and prognosis.
Jing R; Liu S; Jiang Y; Zong W; Ju S; Cui M
Pathol Res Pract; 2020 Dec; 216(12):153261. PubMed ID: 33176259
[TBL] [Abstract][Full Text] [Related]
18. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
